Magnaprin Interactions
There are 669 drugs known to interact with Magnaprin (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide), along with 18 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 79 are major, 526 are moderate, and 64 are minor.
- View all 669 medications that may interact with Magnaprin
- View Magnaprin alcohol/food interactions (4)
- View Magnaprin disease interactions (18)
Most frequently checked interactions
View interaction reports for Magnaprin (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide) and the medicines listed below.
- Actonel with Calcium (calcium carbonate / risedronate)
- amlodipine / atorvastatin
- atropine / diphenoxylate
- calcium citrate
- Carafate (sucralfate)
- carvedilol
- Celexa (citalopram)
- cholestyramine
- citalopram
- clonidine
- Easprin (aspirin)
- ferrous sulfate
- Florastor (saccharomyces boulardii lyo)
- folic acid
- furosemide
- gabapentin
- hydralazine
- indomethacin
- Iron Gluconate (ferrous gluconate)
- Lipitor (atorvastatin)
- lisinopril
- Magnacet (acetaminophen / oxycodone)
- magnesium oxide
- metolazone
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Nasonex (mometasone nasal)
- omeprazole
- omeprazole / sodium bicarbonate
- warfarin
Magnaprin alcohol/food interactions
There are 4 alcohol/food interactions with Magnaprin (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide).
Magnaprin disease interactions
There are 18 disease interactions with Magnaprin (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide) which include:
- constipation
- coagulation
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
Report options
More about Magnaprin (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.